{"id":"544d60e5-523e-4483-bf80-7b3b97783557","kind":"companies","code":"UB-C10543","name":"Xihuoumi","nameBasis":"transliterated","summary":"Provider of AI proteomic diagnostic services.","description":"Provider of AI proteomic diagnostic services.","country":"China","category":null,"originalName":"西湖欧米","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T00:00:00.000Z","englishUpdatedAt":"2026-10-18T08:52:11.987Z","reviewedAt":"2026-10-18T08:52:11.987Z","snapshotAt":"2026-10-17T04:56:34.702Z","sourceHash":"e3f9be43b8c6bf0863845eb726b37c8c33d4a87644996dc214b9bf635928949b","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"人工智能蛋白质组诊断服务提供商","sources":[],"related":[{"id":"4805e491-13f3-4ca9-a185-fed02ca8a5df","kind":"people","code":"UB-P3038","name":"Guo Tiannan","nameBasis":"transliterated","summary":"Dr. Guo Tiannan, founder and chairman of Westlake Omics; proteomics expert, distinguished researcher at Westlake University’s School of Life Sciences and director of Westlake Laboratory’s iMarker Lab (sources: Tianyancha/Westlake University).","description":"Dr. Guo Tiannan, founder and chairman of Westlake Omics; proteomics expert, distinguished researcher at Westlake University’s School of Life Sciences and director of Westlake Laboratory’s iMarker Lab (sources: Tianyancha/Westlake University).","country":null,"category":null,"originalName":"郭天南","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-16T00:00:12.921Z","englishUpdatedAt":"2026-10-16T01:53:04.600Z","reviewedAt":"2026-10-16T01:53:04.600Z","snapshotAt":"2026-10-16T01:37:46.850Z","sourceHash":"29914a1119f156f7858ba68a218c7606bbb70acc6cbadc0621d2c6824368bd3b","companyId":"544d60e5-523e-4483-bf80-7b3b97783557","foundedYear":null,"logoUrl":null,"path":"/people/guo-tiannan"},{"id":"2ffd7320-4d60-4eb1-8f80-286692203350","kind":"news","code":"2ffd7320-4d60-4eb1-8f80-286692203350","name":"Xihuoumi raises an undisclosed amount in strategic financing","nameBasis":"translated-title","summary":"On 2026-07-17, according to Xiniu Data, Xihuoumi completed strategic financing for an undisclosed amount. Investors were Ruijiang Investment. The company is a provider of AI proteomic diagnostic services.","description":"","country":null,"category":null,"originalName":"西湖欧米完成战略投资融资，金额金额未披露","eventDate":"2026-07-17T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T17:18:19.828Z","englishUpdatedAt":"2026-10-15T20:48:35.047Z","reviewedAt":"2026-10-15T20:48:35.047Z","snapshotAt":"2026-10-15T18:31:34.288Z","sourceHash":"8bad2663ac3c407666cda1f40ecdecd1d44295e108d3a695468160028222fcd3","companyId":"544d60e5-523e-4483-bf80-7b3b97783557","foundedYear":null,"logoUrl":null,"path":"/news/2ffd7320-4d60-4eb1-8f80-286692203350"},{"id":"ef67b9b5-1f57-43a7-a265-e81685b85e50","kind":"institutions","code":"UB-I7624","name":"瑞江","nameBasis":"transliterated","summary":"Ruijiang Capital, an early-stage venture capital firm.","description":"Ruijiang Capital, an early-stage venture capital firm.","country":null,"category":null,"originalName":"瑞江","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:18.744Z","englishUpdatedAt":"2026-10-16T01:39:38.813Z","reviewedAt":"2026-10-16T01:39:38.813Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"4823065a70613b455fb376a24011cf3f27eaba6bc961492a39996edd44c62c4a","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Ruijiang","path":"/institutions/ruijiang"}],"finance":{"funding":{"metric":"funding","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"2ffd7320-4d60-4eb1-8f80-286692203350","date":"2026-07-17T00:00:00.000Z","round":"Strategic","amountText":"金额未披露","estimateUsd":null,"estimateLabel":"Undisclosed","estimateNote":null,"investors":"瑞江投资","institutions":[{"id":"ef67b9b5-1f57-43a7-a265-e81685b85e50","kind":"institutions","code":"UB-I7624","name":"瑞江","nameBasis":"transliterated","summary":"Ruijiang Capital, an early-stage venture capital firm.","description":"Ruijiang Capital, an early-stage venture capital firm.","country":null,"category":null,"originalName":"瑞江","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:18.744Z","englishUpdatedAt":"2026-10-16T01:39:38.813Z","reviewedAt":"2026-10-16T01:39:38.813Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"4823065a70613b455fb376a24011cf3f27eaba6bc961492a39996edd44c62c4a","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Ruijiang","path":"/institutions/ruijiang"}],"newsUrl":null,"evidence":{"headline":"Xihuoumi raises an undisclosed amount in strategic financing","brief":"On 2026-07-17, according to Xiniu Data, Xihuoumi completed strategic financing for an undisclosed amount. Investors were Ruijiang Investment. The company is a provider of AI proteomic diagnostic services.","basis":"translated-source-brief","newsPath":"/news/2ffd7320-4d60-4eb1-8f80-286692203350","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"2ffd7320-4d60-4eb1-8f80-286692203350","date":"2026-07-17T00:00:00.000Z","round":"Strategic","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"瑞江投资","institutions":[{"id":"ef67b9b5-1f57-43a7-a265-e81685b85e50","kind":"institutions","code":"UB-I7624","name":"瑞江","nameBasis":"transliterated","summary":"Ruijiang Capital, an early-stage venture capital firm.","description":"Ruijiang Capital, an early-stage venture capital firm.","country":null,"category":null,"originalName":"瑞江","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:18.744Z","englishUpdatedAt":"2026-10-16T01:39:38.813Z","reviewedAt":"2026-10-16T01:39:38.813Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"4823065a70613b455fb376a24011cf3f27eaba6bc961492a39996edd44c62c4a","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Ruijiang","path":"/institutions/ruijiang"}],"newsUrl":null,"evidence":{"headline":"Xihuoumi raises an undisclosed amount in strategic financing","brief":"On 2026-07-17, according to Xiniu Data, Xihuoumi completed strategic financing for an undisclosed amount. Investors were Ruijiang Investment. The company is a provider of AI proteomic diagnostic services.","basis":"translated-source-brief","newsPath":"/news/2ffd7320-4d60-4eb1-8f80-286692203350","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"2ffd7320-4d60-4eb1-8f80-286692203350","kind":"funding","eventDate":"2026-07-17T00:00:00.000Z","revenueDate":null,"round":"战略投资","amountText":"金额未披露","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"瑞江投资","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"ef67b9b5-1f57-43a7-a265-e81685b85e50","kind":"institutions","code":"UB-I7624","name":"瑞江","nameBasis":"transliterated","summary":"Ruijiang Capital, an early-stage venture capital firm.","description":"Ruijiang Capital, an early-stage venture capital firm.","country":null,"category":null,"originalName":"瑞江","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:18.744Z","englishUpdatedAt":"2026-10-16T01:39:38.813Z","reviewedAt":"2026-10-16T01:39:38.813Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"4823065a70613b455fb376a24011cf3f27eaba6bc961492a39996edd44c62c4a","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Ruijiang","path":"/institutions/ruijiang"}],"roundName":"Strategic","amountLabel":"Undisclosed","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[{"id":"4805e491-13f3-4ca9-a185-fed02ca8a5df","kind":"people","code":"UB-P3038","name":"Guo Tiannan","nameBasis":"transliterated","summary":"Dr. Guo Tiannan, founder and chairman of Westlake Omics; proteomics expert, distinguished researcher at Westlake University’s School of Life Sciences and director of Westlake Laboratory’s iMarker Lab (sources: Tianyancha/Westlake University).","description":"Dr. Guo Tiannan, founder and chairman of Westlake Omics; proteomics expert, distinguished researcher at Westlake University’s School of Life Sciences and director of Westlake Laboratory’s iMarker Lab (sources: Tianyancha/Westlake University).","country":null,"category":null,"originalName":"郭天南","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-16T00:00:12.921Z","englishUpdatedAt":"2026-10-16T01:53:04.600Z","reviewedAt":"2026-10-16T01:53:04.600Z","snapshotAt":"2026-10-16T01:37:46.850Z","sourceHash":"29914a1119f156f7858ba68a218c7606bbb70acc6cbadc0621d2c6824368bd3b","companyId":"544d60e5-523e-4483-bf80-7b3b97783557","foundedYear":null,"logoUrl":null,"path":"/people/guo-tiannan"}],"productsRelated":[],"investors":[{"id":"ef67b9b5-1f57-43a7-a265-e81685b85e50","kind":"institutions","code":"UB-I7624","name":"瑞江","nameBasis":"transliterated","summary":"Ruijiang Capital, an early-stage venture capital firm.","description":"Ruijiang Capital, an early-stage venture capital firm.","country":null,"category":null,"originalName":"瑞江","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:18.744Z","englishUpdatedAt":"2026-10-16T01:39:38.813Z","reviewedAt":"2026-10-16T01:39:38.813Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"4823065a70613b455fb376a24011cf3f27eaba6bc961492a39996edd44c62c4a","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Ruijiang","path":"/institutions/ruijiang"}],"path":"/companies/UB-C10543","structured":{"city":null,"country":"China","location":null,"role":null,"category":null,"company":null},"definition":"Xihuoumi is a company headquartered in China.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/companies/UB-C10543"}